Literature DB >> 2862828

Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.

B S Bunney, L A Chiodo, A S Freeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2862828     DOI： 10.1111/j.1749-6632.1985.tb29929.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.

Authors:  J G Csernansky; S Glick; J Mellentin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.

Authors:  S Tanganelli; K Fuxe; G von Euler; L F Agnati; L Ferraro; U Ungerstedt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

3.  The effects of quinacrine, proglumide, and pentoxifylline on seizure activity, cognitive deficit, and oxidative stress in rat lithium-pilocarpine model of status epilepticus.

Authors:  Mohammad Ahmad; Gasem M Abu-Taweel; Ahmad E Aboshaiqah; Jamaan S Ajarem
Journal:  Oxid Med Cell Longev       Date:  2014-11-16       Impact factor: 6.543

Review 4.  How Negative Experience Influences the Brain: A Comprehensive Review of the Neurobiological Underpinnings of Nocebo Hyperalgesia.

Authors:  Mia A Thomaidou; Kaya J Peerdeman; Melissa I Koppeschaar; Andrea W M Evers; Dieuwke S Veldhuijzen
Journal:  Front Neurosci       Date:  2021-03-24       Impact factor: 4.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.